Verification of imatinib cost-effectiveness in advanced gastrointestinal stromal tumor in British Columbia (VINCE-BC study).
about
Prevalence of gastrointestinal stromal tumour (GIST) in the United Kingdom at different therapeutic lines: an epidemiologic modelCost-effectiveness analyses of targeted oral anti-cancer drugs: a systematic review.Advances in cancer therapeutics and patient access to new drugs.Cost-Effectiveness Analysis of Tyrosine Kinase Inhibitors for Patients with Advanced Gastrointestinal Stromal Tumors.Insights into cancer surveillance in Central and Eastern Europe, Israel and Turkey.
P2860
Verification of imatinib cost-effectiveness in advanced gastrointestinal stromal tumor in British Columbia (VINCE-BC study).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Verification of imatinib cost- ...... ish Columbia (VINCE-BC study).
@en
Verification of imatinib cost- ...... omal tumor in British Columbia
@nl
type
label
Verification of imatinib cost- ...... ish Columbia (VINCE-BC study).
@en
Verification of imatinib cost- ...... omal tumor in British Columbia
@nl
prefLabel
Verification of imatinib cost- ...... ish Columbia (VINCE-BC study).
@en
Verification of imatinib cost- ...... omal tumor in British Columbia
@nl
P2093
P2860
P356
P1476
Verification of imatinib cost- ...... ish Columbia (VINCE-BC study).
@en
P2093
Christina Cy Chu
Karissa Johnston
Meg Knowling
Suzanne Cm Taylor
Veronika Moravan
Vincent H Mabasa
P2860
P304
P356
10.1177/1078155208088695
P577
2008-06-04T00:00:00Z